Esperion Therapeutics, Inc. ($ESPR)
Filing Information
| Accession Number | 0001628280-26-018194 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 16, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
570,070
Total Value
$0.00
P&L
+inf% (+$1,453,678.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Mar 13, 2026 | Grant/Award | 300,840 | $0.00 | $0.00 | 685,056 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (right to buy) | Derivative | Mar 13, 2026 | Grant/Award | 269,230 | $0.00 | $0.00 | 269,230 | Direct | โ | View Details |